PAG-backed Chinese biopharma BioRay raises $218m at $1.9b pre-money valuation

PAG-backed Chinese biopharma BioRay raises $218m at $1.9b pre-money valuation

Laboratory equipment. Photo: Pixabay

05 January, 2023

autoimmune biopharmaceutical BioRay Pharmaceutical PAG

Printed by Unregistered user on Wed, 06 Aug 2025 18:56:27 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

iQIYI, China's answer to Netflix, raises $500m from private placement to PAG

Hong Kong’s PAG closes APAC’s largest private credit fund at $2.6b

Read more from Greater China

Trustar Capital raises $626m RMB M&A fund targeting control buyouts in China

Venture Capital

PaXini closes JD-led deal; raises nearly $140m in four months